Abstract
The epidermis is a model particularly well suited to the study of cell proliferation and differentiation, and of alterations of these processes such as carcinogenesis. Compartmentalization exists in this tissue, with the proliferative, less differentiated cells confined to the basal layer and the terminally differentiating, non-proliferative cells moving upwards to the surface through distinct layers. Different genes are expressed throughout this process in a stage-of-differentiationspecific manner, and their promoters have been very useful in directing precise gene expression in transgenic mice. Other attractive characteristics of the epidermis include its external localization, which facilitates manipulation and observation, the possibility of obtaining primary keratinocytes that can be easily cultured and manipulated in vitro, and the existence of well-established protocols for chemical and UV carcinogenesis. The latter are invaluable tools for assessing the in vivo functions of the genes targeted in transgenic mice. These characteristics have made the epidermis a widely used model system in recent years for the study of molecular mechanisms of carcinogenesis. A wealth of transgenic mice generated using epidermal-specific promoters, as well as knockout animals, have been used to examine the role of genes involved in processes such as cell cycle control, cell signaling, cell growth and differentiation, and angiogenesis in tumor and metastasis growth. Cre / loxP technology will allow a new generation of mice that allows the study of cancer genetics in a cell type-and time-controlled manner, more closely resembling the conditions found in the development of neoplasms.
Keywords: skin carcinogenesis, uv carcinogenesis, cre/loxp
Current Genomics
Title: Understanding Mouse Skin Carcinogenesis through Transgenic Approaches
Volume: 3 Issue: 4
Author(s): Fernando Larcher, Angel Ramirez, M. Llanos Casanova, Manuel Navarro, Jesus M. Paramio, Paloma Perez, Angustias Page, Mirentxu Santos and Jose L. Jorcano
Affiliation:
Keywords: skin carcinogenesis, uv carcinogenesis, cre/loxp
Abstract: The epidermis is a model particularly well suited to the study of cell proliferation and differentiation, and of alterations of these processes such as carcinogenesis. Compartmentalization exists in this tissue, with the proliferative, less differentiated cells confined to the basal layer and the terminally differentiating, non-proliferative cells moving upwards to the surface through distinct layers. Different genes are expressed throughout this process in a stage-of-differentiationspecific manner, and their promoters have been very useful in directing precise gene expression in transgenic mice. Other attractive characteristics of the epidermis include its external localization, which facilitates manipulation and observation, the possibility of obtaining primary keratinocytes that can be easily cultured and manipulated in vitro, and the existence of well-established protocols for chemical and UV carcinogenesis. The latter are invaluable tools for assessing the in vivo functions of the genes targeted in transgenic mice. These characteristics have made the epidermis a widely used model system in recent years for the study of molecular mechanisms of carcinogenesis. A wealth of transgenic mice generated using epidermal-specific promoters, as well as knockout animals, have been used to examine the role of genes involved in processes such as cell cycle control, cell signaling, cell growth and differentiation, and angiogenesis in tumor and metastasis growth. Cre / loxP technology will allow a new generation of mice that allows the study of cancer genetics in a cell type-and time-controlled manner, more closely resembling the conditions found in the development of neoplasms.
Export Options
About this article
Cite this article as:
Larcher Fernando, Ramirez Angel, Casanova Llanos M., Navarro Manuel, Paramio M. Jesus, Perez Paloma, Page Angustias, Santos Mirentxu and Jorcano L. Jose, Understanding Mouse Skin Carcinogenesis through Transgenic Approaches, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350345
DOI https://dx.doi.org/10.2174/1389202023350345 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms of Activation and Key Roles of SGK3 Under Physiological Conditions and in Prostate and Breast Cancer
Current Signal Transduction Therapy Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Prolylcarboxypeptidase Gene Expression in the Heart and Kidney: Effects of Obesity and Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Acridone-based Antitumor Agents: A Mini-review
Anti-Cancer Agents in Medicinal Chemistry Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies
Current Pharmaceutical Design Probiotics as a Tool to Biosynthesize Metallic Nanoparticles: Research Reports and Patents Survey
Recent Patents on Drug Delivery & Formulation Cytokine Antibody Arrays in Biomarker Discovery and Validation
Current Proteomics Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor
Current Pharmaceutical Design Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic Markers
Current Genomics Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and Inflammation
Current Pharmaceutical Design Chemoprevention Gene Therapy (CGT): Novel Combinatorial Approach for Preventing and Treating Pancreatic Cancer
Current Molecular Medicine Stem Cell Dynamics and Heterogeneity: Implications for Epidermal Regeneration and Skin Cancer
Current Medicinal Chemistry Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Role of Alterations in the Apoptotic Machinery in Sensitivity of Cancer Cells to Treatment
Current Pharmaceutical Design The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Regulation of Cytochrome P450 Expression by Ras- and β-Catenin-Dependent Signaling
Current Drug Metabolism Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Chondroitin Sulphate Decorated Polymeric Nanoparticles: An Effective Carrier for Enhancement of Lung Cancer Targeting Capabilities of Anticancer Drug
Current Nanomedicine Exploiting APC Function as a Novel Cancer Therapy
Current Drug Targets